Albemarle (NYSE: ALB) reported Q2 EPS of $0.11, $0.89 better than the analyst estimate of ($0.78). Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.22 billion.

OUTLOOK

• Reducing full-year 2025 capital expenditure outlook to between $650 and $700 million.
• Maintaining full-year outlook considerations; the previously published $9/kg scenario ranges are expected to apply assuming current lithium market pricing persists for the remainder of the year.

For earnings history and earnings-related data on Albemarle (ALB) click here.